
Company valuation, historical trends, and peer comparisons.
According to Assembly Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 371.37M. This represents a change of 3.87% compared to the average of 357.55M of the last 4 quarters.
The mean historical Enterprise Value of Assembly Biosciences, Inc. over the last ten years is 323.56M. The current 371.37M Enterprise Value has changed 14.78% with respect to the historical average. Over the past ten years (40 quarters), ASMB's Enterprise Value was at its highest in in the March 2018 quarter at 1.13B. The Enterprise Value was at its lowest in in the March 2023 quarter at 1.99M.
Average
323.56M
Median
230.70M
Minimum
13.98M
Maximum
881.81M
Discovering the peaks and valleys of Assembly Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 447.02%
Maximum Annual Enterprise Value = 881.81M
Minimum Annual Increase = -77.34%
Minimum Annual Enterprise Value = 13.98M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 325.46M | 447.02% |
| 2024 | 59.50M | 116.02% |
| 2023 | 27.54M | 97.03% |
| 2022 | 13.98M | -77.34% |
| 2021 | 61.69M | -74.16% |
| 2020 | 238.76M | -71.12% |
| 2019 | 826.82M | 43.19% |
| 2018 | 577.41M | -34.52% |
| 2017 | 881.81M | 296.07% |
| 2016 | 222.64M | 94.65% |
The current Enterprise Value of Assembly Biosciences, Inc. (ASMB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
137.50M
5-year avg
97.63M
10-year avg
323.56M
Assembly Biosciences, Inc.’s Enterprise Value is less than Arbutus Biopharma Corp (810.52M), greater than Aligos Therapeutics, Inc. (4.10M), greater than Enanta Pharmaceuticals, Inc. (326.89M), greater than Atea Pharmaceuticals, Inc. (251.11M), less than Vir Biotechnology, Inc. (1.72B), greater than Cocrystal Pharma, Inc. (19.50M), greater than Indaptus Therapeutics, Inc. (358.22M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 810.52M | $826.06M | |
| 4.10M | $30.97M | |
| 326.89M | $304.65M | |
| 251.11M | $327.24M | |
| 1.72B | $1.91B | |
| 19.50M | $20.33M | |
| 358.22M | $365.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assembly Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Assembly Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Assembly Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Assembly Biosciences, Inc. (ASMB)?
What is the 3-year average Enterprise Value for Assembly Biosciences, Inc. (ASMB)?
What is the 5-year average Enterprise Value for Assembly Biosciences, Inc. (ASMB)?
How does the current Enterprise Value for Assembly Biosciences, Inc. (ASMB) compare to its historical average?